CSB Bank Earnings Call Transcripts
Fiscal Year 2026
-
FY 2026 saw robust profit and asset growth, with net profit up 7% and advances up 27% year-over-year. Asset quality improved to multi-quarter lows in NPAs, and the bank completed a major tech upgrade, positioning for future retail and SME growth.
-
Operating profit rose 32% YoY, with advances up 29% and deposits up 21%, outpacing the industry. Asset quality saw a slight dip, but management expects upgrades and improved credit costs ahead. Gold loans remain a key driver, but the bank aims to diversify its portfolio.
-
Q2 FY 2026 saw robust growth in profit, operating income, and advances, with strong asset quality and improved margins. Technology transformation and diversification efforts position the bank for sustainable 25%-30% annual growth, with credit costs guided at 40-50 bps.
-
Q1 FY 2026 saw robust YoY growth in deposits (20%) and advances (31%), with net profit up 5% and operating profit up 28%. Asset quality remains strong, and a major tech transformation was completed, positioning for future scalability.
Fiscal Year 2025
-
Net profit grew 5% year-over-year to INR 594 crore, with strong advances and deposit growth outpacing the industry. NIM is expected to stabilize near 4% in FY26, and a major tech transformation is underway to support future scaling and diversification.
-
Q3 FY25 saw 10% QoQ net profit growth, 26% YoY advances growth, and improved asset quality. NIM held at 4.11% despite yield compression, with strong capital and liquidity. Tech transformation and retail asset expansion are key focus areas.
-
Q2 FY25 saw net profit rise 22% sequentially, with strong deposit and loan growth outpacing the industry. Asset quality and capital ratios remain robust, while technology transformation and conservative provisioning support long-term growth.
-
Net profit reached INR 113 crore with strong deposit and advance growth, though NIM was compressed by regulatory changes and higher funding costs. Asset quality remained stable, and management reaffirmed full-year NIM and ROA guidance, expecting improvement from Q2.